Principles of Pharma Market Access in Europe


08 December 2020


Registration Deadline


  • What Market Access means to the industry and the different categories of payers.
  • The Market Access systems in France, Germany, Italy, Spain and the UK, and how to compare differences across the EU.
  • The difference between hospital and retail/primary care decision making.
  • Understand payers: Their drivers, their perspectives and decision-making processes.
  • How to develop a Market Access Plan, from pre-phase II up to launch, including strategies and tactics.
  • How to communicate value in your product story.
  • How to optimise the Value Dossier to address various stakeholder needs.